Clareon CCWET3 (UDI 00380652455190)Recalls & reported problems
Alcon Laboratories, Inc. · Clareon Vivity Toric UVA · Class 3 · Implant
All models of Clareon (1142)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 3
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 00380652455190), received between Dec 27, 2022 and Mar 14, 2025 — classified as 3 injuries, 1 malfunction.
The most frequently reported specific device problem is “Defective Device” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Defective Device1
- Device Dislodged or Dislocated1
- Difficult to Advance1
Patient problems
- Visual Impairment3
- Blurred Vision2
- Insufficient Information1
- No Clinical Signs, Symptoms or Conditions1
- Visual Disturbances1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryMar 14, 2025Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, LENS WAS EXPLANTED AT SECONDARY PROCEDURE DUE TO PATIENT EXPERIENCED POOR VISION ACUITY. CLINICAL REASON FOR EXPLANT WAS REPORTED TO BE RESIDUAL ASTIGMATISM. THE IOL WAS REPLACED WITH UNSPECIFIED LENS APPROXIMATELY FIVE MONTHS AFTER INITIAL PROCEDURE. ADDITIONAL INFORMATION WAS REQUESTED.
Patient problems: Visual Impairment
MAUDE report 21606204 ↗InjuryAug 22, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A CONSUMER REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE ON (B)(6) IN THE LEFT EYE, DISAPPOINTED IN THAT THE INTERMEDIATE VISION FOCAL LENGTH, WHILE IMPROVED, WAS NOT 20/20, PATIENT WAS REFERRING TO A RANGE OF 5 TO 20 FEET IN DISTANCE. IN PARTICULAR, WATCHING A 65' HIGH DEF TV WITH UHD STILL REQUIRES GLASSES TO ACHIEVE COMPLETE ACUITY AND SHARPNESS. ESTIMATED VISION AT THAT DISTANCE TO BE ABOUT 20/25. CONSUMER AGREES THAT THE LONG RANGE (I.E., DRIVING) WAS 20/20 AND COULD USUALLY MAKE OUT INSTRUMENT PANEL IN THE CAR, BUT SOMEWHAT BLURRED. ADDITIONAL INFORMATION WAS REQUESTED AND RECEIVED STATING THAT THE PATIENT WANTED TO KNOW WHY HIS LEFT EYE VISION WAS NOW LESS THAN THE RIGHT WHEN IT WAS THE STRONGER OF THE TWO MID RANGE. AND WHY "FUNCTIONAL VISION" WAS WORSE FOR CLOSE RANGE THAN BEFORE THE IMPLANTS. WHILE HE EAT OR READ, MY FOOD OR PHONE WAS BLURRY THAN PRIOR TO IMPLANTS. THE PRESCRIPTION WAS THE CURRENT GLASSES THAT HE WEAR TO WATCH TV AND READ THE COMPUTER. PATIENT EXPERIENCED NIGHT TIME DRIVING HARDER THAN BEFORE. HAD HALOS AND TAIL LIGHTS WERE LIKE STARBURSTS. HE STARTED EXPERIENCING SYMPTOMS ONE MONTH AFTER SURGERY. LEFT EYE WAS THE STRONGER (SHARPER)
Patient problems: Blurred Vision; Visual Disturbances; Visual Impairment
MAUDE report 20037988 ↗InjuryApr 25, 2024Device Dislodged or Dislocated; Device Dislodged or Dislocated
A NON-HEALTHCARE PROFESSIONAL REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED BLURRY, SLIGHT TORIC ROTATION AND UNDER CORRECTION OF ASTIGMATISM. THE IOL WAS EXCHANGED FOR ANOTHER LENS MODEL 1 MONTHS 6 DAYS FOLLOWING THE INITIAL IMPLANT PROCEDURE. THE SURGEONS PROGNOSIS WAS MENTIONED AS GOOD.
Patient problems: Blurred Vision; Visual Impairment
MAUDE report 19181658 ↗MalfunctionDec 27, 2022Defective Device; Difficult to Advance; Defective Device; Difficult to Advance
A NON HEALTHCARE PROFESSIONAL REPORTED THAT DURING UPON INJECTION OF THE LENS THE DOCTOR NOTED THAT HE DID NOT LIKE THE APPEARANCE OF THE LENS. THE SURGERY WAS COMPLETED WITH A BACK UP LENS. ADDITIONAL INFORMATION HAS BEEN REQUESTED AND RECEIVED STATING THAT IN THE PROCESS OF BEING INJECTED INTO THE PATIENT'S EYE, THE LENS WAS NOT INJECTING PROPERLY. THE SURGICAL TECHNICIAN RELOADED THE LENS AND A SECOND INJECTION WAS ATTEMPTED. UPON INJECTION OF THE LENS, THE DOCTOR DID NOT LIKE THE APPEARANCE OF THE LENS.
Patient problems: Insufficient Information; No Clinical Signs, Symptoms or Conditions
MAUDE report 16050832 ↗
Other intraocular lens devices
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens146 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens145 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens144 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens139 reports
- TECNIS SIMPLICITY DIB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens1 recall81 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens129 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens127 reports
- TECNIS IOL PCB00Johnson & Johnson Surgical Vision, Inc. · intraocular lens126 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page